期刊文献+

川崎病患儿血清抗内皮细胞抗体和抗中性粒细胞胞浆抗体检测的临床意义 被引量:6

Clinical significance of anti-neutrophil cytoplasmic antibodies and anti-endothelial cell antibodies in children with Kawasaki disease
原文传递
导出
摘要 目的探讨抗内皮细胞抗体(AECA)和抗中性粒细胞胞浆抗体(ANCA)在川崎病(KD)及其冠状动脉损害(CAL)中的临床意义。方法应用酶联免疫吸附试验定量检测42例KD患儿急性期、缓解期血清AECA和ANCA水平,并行心脏超声心动图了解CAL发生情况。随机选取20例因呼吸道感染发热患儿和15例外科择期手术患儿分别作为发热对照组和普通对照组。结果急性期KD组AECA、ANCA水平均显著高于两对照组(P<0.01)。与急性期相比,KD组缓解期血清ANCA水平下降(P<0.01),但仍高于发热对照组和普通对照组(P<0.05)。伴有CAL的KD患儿急性期血清ANCA水平明显高于无CAL患儿(P<0.01),且伴CAL患儿血清ANCA与左冠脉内径与主动脉瓣环内径比值呈正相关关系(r=0.88,P<0.01)。结论 AECA、ANCA可能参与了KD血管炎及其CAL的发生。急性期血清AECA、ANCA对早期难以确诊的KD有参考价值,ANCA水平异常增高对CAL有一定的预警价值。 Objective To study the clinical significance of anti-endothelial cell antibodies(AECA) and antineutrophil cytoplasmic antibodies(ANCA) in Kawasaki disease(KD) and its complication of coronary arterial lesions(CAL). Methods Forty-two children with KD, as well as 20 children with fever caused by respiratory infection(fever control group) and 15 children for selective operation(normal control group), were included in the study. Serum levels of AECA and ANCA were measured using enzyme-linked immunosorbent assay. Echocardiography was performed to evaluate CAL in KD patients. Results During the acute phase, the KD patients had significantly higher serum AECA and ANCA levels than the two control groups(P〈0.01). The KD patients had reduced serum ANCA levels(P〈0.01) in the remission phase, but they were still higher than those of the two control groups(P〈0.05). Among KD patients, those with CAL had significantly higher ANCA levels than those without CAL(P〈0.01) in the acute phase. There was a positive correlation between serum ANCA levels and the ratio of left coronary artery to aortic annular diameter in KD patients with CAL(r=0.88, P〈0.01). Conclusions AECA and ANCA may be involved in vasculitis and CAL among children with KD. Serum levels of AECA and ANCA may be used as indicators for the diagnosis of suspected KD cases in the acute phase. Elevated ANCA level has a certain predictive value for CAL.
出处 《中国当代儿科杂志》 CAS CSCD 北大核心 2014年第7期740-744,共5页 Chinese Journal of Contemporary Pediatrics
基金 江苏省卫生厅面上科研项目(H201423) 南通市社会事业科技创新与示范计划(HS2012048)
关键词 川崎病 抗内皮细胞抗体 抗中性粒细胞胞浆抗体 冠状动脉损害 儿童 Kawasaki disease Anti-endothelial cell antibody Anti-neutrophil cytoplasmic antibody Coronary artery lesion Child
  • 相关文献

参考文献15

  • 1Guilpain P, Mouthon L. Antiendothelial cells autoantibodies in aseulitis-associated systemic diseases[J]. Clin Rev Allergy Immunol, 2008, 35(1-2): 59-65.
  • 2Hagen EC, Daha MR, Hermans J, et al. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization[J]. Kidney Int, 1998, 53(3):743-753.
  • 3Japaness Circulation Society Joint Research Group. Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease[J]. Pediatr Int, 2005, 47(6): 711-732.
  • 4Belay ED, Maddox RA, Holman RC, et al. Kawasaki syndrome and risk factors for coronary artery abnormalities: United States, 1994-2003[J]. Pediatr Infect Dis J, 2006, 25(3): 245-249.
  • 5黄国英,吴瑶.川崎病冠状动脉病变的危险分层与处理对策[J].临床儿科杂志,2010,28(7):611-613. 被引量:14
  • 6Kobayashi S, Fujimoto S, Takahashi K, et al. Anti-neutrophil cytoplasmic antibody-associated vasculitis, large vessel vasculitis and Kawasaki disease in Japan[J]. Kidney Blood Press Res, 2010, 33(6): 442-455.
  • 7Kuo HC, Yu HR, Juo SH, et al. CASP3 gene single-nucleotide polymorphism (rs72689236) and Kawasaki disease in Taiwan Residents children[J]. J Hum Genet, 2011, 56(2): 161-165.
  • 8Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association[J]. Circulation, 2004, 110(17): 2747-2771.
  • 9Grunebaum E, Blank M, Cohen S, et al. The role of anti- endothelial cell antibodies in Kawasaki disease - in vitro and in vivo studies[J]. Clin Exp Immunol, 2002, 130(2): 233-240.
  • 10Karasawa R, Fujieda M, Yudoh K. Detection of specific markers: our research on the marker in patients with Kawasaki disease[J]. Nihon Rinsho Meneki Gakkai Kaishi, 2010, 33(4): 207-213.

二级参考文献45

  • 1郭东更,宫怡.抗中性粒细胞胞浆抗体在风湿性疾病中的作用机制[J].临床荟萃,2006,21(24):1800-1801. 被引量:8
  • 2De Zorzi A,Colan SD,Gauvreau K,et al.Coronary artery dimensions may be misclassified as normal in Kawasaki disease[J].J Pediatr,1998,133(2):254-258.
  • 3黄国英.冠状动脉并发症的诊断[M] //杜忠东.川崎病.北京:科学技术文献出版社,2009:131-135.
  • 4Belay ED,Maddox RA,Holman RC,et al.Kawasaki syndrome and risk factors for coronary artery abnormalities:United States,1994-2003[J].Pediatr Infect Dis J,2006,25(3):245-249.
  • 5Japanese Circulation Society Joint Research Group.Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease[J].Pediatr Int,2005,47(6):711-714.
  • 6Satou GM,Giamelli J,Gewitz MH,et al.Kawasaki disease:diagnosis,management,and long-term implications[J].Cardiol Rev,2007,15(4):163-169.
  • 7Tsuda E,Kamiya T,Ono Y,et al.Incidence of stenotic lesions predicted by acute phase changes in coronary arterial diamete during Kawasaki disease[J].Pediatr Cardiol,2005,26(1):73-79.
  • 8Newburger JW,Takahashi M,Gerber MA,et al.Diagnosis,treatment,and long-term management of Kawasaki disease:a statement for health professionals from the committee on rheumatic fever,endocarditis,and Kawasaki disease,council on cardiovascular disease in the young,American Heart Association[J].Pediatrics,2004,114(6):1708-1733.
  • 9Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association [ J ]. Pediatrics, 2004, 114 (6) : 1708-1733.
  • 10Ayusawa M, Sonobe T, Uemura S, Ogawa S, Nakamura Y, Kiyosawa N, et al. Revision of diagnostic guidelines for Kawasadi disease (the 5th revised edition) [ J]. Pediatr Int, 2005, 47 (2) : 232-234.

共引文献21

同被引文献48

  • 1许煊.24例儿童川崎病的早期诊断及冠状动脉扩张高危因素分析[J].暨南大学学报(自然科学与医学版),2005,26(2):255-257. 被引量:2
  • 2胡亚美 江载芳.诸福棠实用儿科学[M]第7版[M].北京:人民卫生出版社,2002.1514.
  • 3Newburger JW, TakahashiM, Burns JC, et al. The treatment of Kawasaki syndrome with intravenous gamma globulin [J]. N Engl J Med, 1986, 315(6): 341-347.
  • 4Sato YZ, Molkara DP, Daniels LB, et al. Cardiovascular biomarkers in acute kawasaki disease[J]. Int J Cardiol, 2013, 164(1): 58-63.
  • 5Kobayashi T, Inoue Y, Takeuchi K, et al. Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease[J]. Circulation, 2006, 113(22): 2606-2612.
  • 6Japanese Circulation Society Joint Research Group. Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease [J]. Pediatr Int, 2005, 47(6): 711-732.
  • 7Baker AL, Lu M, Minich LL, et al. Associated symptoms in the ten days before diagnosis of Kawasaki disease[J]. J Pediatr, 2009, 154(4): 592-595.
  • 8Eladawy M, Dominguez SR, Anderson MS, et al. Abnormal liver panel in acute Kawasaki disease[J]. Pediatr Infect Dis J, 2011, 30(2): 141-144.
  • 9王秦,刘秀梅,刘爱武,郝轶群,赵凤梅.系统性红斑狼疮循环易栓因子及其与临床的相关性研究[J].中国医药,2008,3(3):181-182. 被引量:5
  • 10陈晶晶,黄敏,谢利剑,李锦康,杨晓东.川崎病冠状动脉损害高危因素的研究[J].临床儿科杂志,2009,27(5):442-445. 被引量:11

引证文献6

二级引证文献67

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部